Abstract: Cement mixtures comprising a hydration retarder comprising algae, cement additives comprising algae and/or derivatives thereof, and methods of forming and using the mixtures and additives are disclosed. The algae can be treated to form desired functional groups to tune retardation properties of the hydration retarder.

Abstract: A method of treating prostate cancer in a patient comprising administering to the patient a pharmaceutical composition including a first therapeutic including a TLK1B inhibitor, or a pharmaceutically acceptable salt, solvate, ester, amide, clathrate, stereoisomer, enantiomer, prodrug or analog thereof, and a second therapeutic including an antiandrogen or a pharmaceutically acceptable salt, solvate, ester, amide, clathrate, stereoisomer, enantiomer, prodrug or analog thereof.

Abstract: A method for efficiently removing Cu in electric furnace steelmaking with regenerated steel raw materials comprises removing Cu in the electric furnace steelmaking and removing Cu deeply in RH/VOD steelmaking. The removing Cu in electric furnace steelmaking comprises removing Cu by spraying CaO—CaCl2—O2 in stages in the electric furnace steelmaking; the removing Cu deeply in the R/VOD steelmaking comprises removing Cu deeply by dynamically blowing CaCl2—O2 based on vacuum degree. Cu removing and Cu removing deeply are performed in the electric furnace steelmaking and the RH/VOD refining process based on the Cu removal principle of selective chlorination by high-oxygen-potential microcells manufactured in electric furnace steelmaking molten pool and on the RH/VOD refined steel liquid level and the high-vacuum smelting environment in the RH/VOD refining process fully utilized; the cost is low, the copper removing efficiency is high, and large-scale industrial production are facilitated.

Abstract: Methods and apparatus for drying foodstuff such as nuts, fruits, and vegetables above ground with natural airflow that is typical during the drying season. The apparatus can be configured for placement with a container or integrated into the interior of a container, such as stationary containers, moveable containers, trailer containers, above-ground containers, and containers with sidewalls through which air can flow.

Abstract: An ammonia fuel cell system capable of rapid adsorption-and-desorption switching by ammonia self-evaporation includes an ammonia decomposition reactor; an ammonia tank; a first heat exchanger; a fuel tank; a first blower; a second heat exchanger; an adsorption column device; a fuel cell; a gas circulation system; and an exhaust gas combustion system, wherein an outlet of the ammonia tank connects with an ammonia gas inlet of the ammonia decomposition reactor, wherein a decomposition gas outlet of the ammonia decomposition reactor, through the first heat exchanger, connects with an adsorption inlet of the adsorption column device, wherein a product produced by decomposition of ammonia gas in the ammonia decomposition reactor preheats a raw ammonia gas via the first heat exchanger, wherein the fuel tank connects with the ammonia decomposition reactor for feeding a fuel gas to the ammonia decomposition reactor.

Abstract: A method for supporting adaptive unloading of multi-Internet of Things (IoT) applications in an edge environment includes: constructing an application compliant with a universal program structure supporting on-demand computing unloading; for the application compliant with the universal program structure supporting on-demand computing unloading, extracting a program fragment flowchart through static code analysis to provide internal flow information of the application for generation of an unloading solution; analyzing a peripheral mobile edge computing (MEC) environment and the application through an unloading solution generating algorithm based on a multi-task particle swarm optimization-genetic algorithm to obtain the optimal unloading solution; and performing, by the application, computing unloading by taking a service as a particle size according to the unloading solution to minimize a system overhead under a circumstance that a deadline constraint of each application is satisfied.

Abstract: The present invention discloses a vaccine formulation in accordance with an illustrative embodiment. The formulation including a live attenuated cholera vaccine strain VCUSM14P; a vaccine medium having starch, cellulose, dextrose, and yeast extract; and a phosphate buffer saline.

Abstract: Disclosed herein are compounds of the Formula (I) or (II) or (III): Also disclosed are methods for stimulating an immune response, inducing an anti-tumor immune response, and treating an infectious disease in a subject by administering a therapeutically effective amount of a compound disclosed herein. Also disclosed are methods of treating a tumor or abnormal cell proliferation by administering a therapeutically effective amount of a compound disclosed herein under conditions effective to treat a tumor or abnormal cell proliferation.

Abstract: An object of the present invention is to provide an industrially easily available hatching factor on Globodera pallida larvae, a control agent and a control method using the same.

Abstract: A cable force control method includes: establishing a friction model, and calibrating parameters; and calculating the parameters in real time, and controlling a force: identifying the parameters according to the friction model to obtain parameters of an auxiliary cable Bowden system and a power Bowden system: a friction coefficient ?a of the auxiliary cable Bowden system, and a friction coefficient ?p of the power cable Bowden system; calculating the auxiliary cable Bowden system ?a in real time according to the model and a force value of a sensor, and using same as a cable bending angle of the power cable Bowden system ?; and obtaining an inverse control formula Fin=Fout·e?u?? according to the friction model, and bringing the power cable Bowden system ?p into the inverse control formula to serve as a feedforward controller, so as to achieve an effect of real-time force control.

Abstract: The present disclosure provides humanized antibodies and antigen-binding fragments thereof that specifically bind to SFRP2 and compositions comprising such humanized antibodies or antigen-binding fragments thereof. In some aspects, the humanized antibodies or antigen-binding fragments can be used to treat diseases or conditions associated with increased SFRP2, such as cancer. In some aspects, the antibodies or antigen-binding fragments can be used to treat osteosarcoma.

Abstract: The present disclosure relates to an immune-enhanced virus vaccine based on virus surface engineering. A linker peptide according to one aspect has the property of being attachable to a virus, and may be used as a linker that may effectively bind an immune-enhancing substance, which activates the immune system, to the surface of the virus, and thus may improve the immunogenicity of the vaccine. By incorporating the linker peptide into virus surface engineering technology, an immune-enhancing substance may be attached to the surface of the virus, which may be useful in an immune-enhanced vaccine platform.

Abstract: The present application relates to devices that assist the human trunk, and provides a device for human trunk assistance, which includes: a trunk link (1), coupled to an upper back of a user through back straps (2); two thigh links (3), coupled to left and right thighs of the user through leg straps (4) respectively; two hip joint hinges (5), placed align to left and right hip joints of the user respectively, and configured for rotatably coupling the trunk link (1) and the two thigh links (3); and a torque generator (6), coupling to the two hip joint hinges (5) through Bowden cables (7), and configured to generate an assist torque to reduce moment burden to the user.

Abstract: A method for anchoring and modifying a nano-drug on the surface of a living cell includes: introducing an active reactive group to a living cell surface by a hydrophobic tail chain of a cell membrane anchoring molecule; modifying the nano-drug surface with a corresponding reactive group; and executing a biological orthogonal click reaction on the active reactive group modified on the living cell surface and the corresponding reactive group modified on the nano-drug surfae, to anchor and modify the nano-drug to the cell surface obtaining a living cell modified with the nano-drug. The method provides a new technical platform for cell modification and has very wide application prospects. Compared with pure cells and pure nano-drugs, a cell drug obtained by the above-mentioned cell modification technology has an optimal treatment effect and provides a new idea and a new drug for treating various diseases.

Abstract: Proposed is a treatment system using vagus nerve stimulation. The treatment system includes a treatment part including an electrode configured to be worn on at least one of the left and right ears and configured to generate electrical stimulation on the vagus nerve in the auricle, a controller configured to transmit an electrical stimulation signal for generating the electrical stimulation to the treatment part, an input part configured to allow a user to input user information, and a measurement part configured to measure biometric information on the user. The controller adjusts an intensity and a pattern of the electrical stimulation on the basis of the biometric information measured by the measurement part, and adjusts a treatment protocol including treatment time and treatment intensity on the basis of the biometric information measured by the measurement part and the user information input by the input part.

Abstract: An intestinal bacteria reducing agent of the present invention is a reducing agent which contains silicon particles or silicon fine particles and reduces the number of bacteria in the intestine. The intestinal bacteria reducing agent can reduce the number of bacteria in the intestine by a new action that cannot be explained by the heretofore known hydrogen generating capability of silicon particles or silicon fine particles, that is, the capability of eliminating hydroxyl radicals.

Abstract: The present invention relates to a brain signal-based user assisting method including the steps of: acquiring learning data for setting a designated command; setting one of a plurality of designated command candidates as a designated command, based on the acquired learning data; performing a background process for recognizing the designated command; determining whether the designated command is recognized continuously more than given times, based on the background process; and if it is determined that the designated command is recognized continuously more than the given times, performing a user's brain signal recording.

Abstract: A semi-supervised machine learning system and method to detect ransomware using low-level hardware information. Employing semi-supervised learning method on performance counter data for anomaly prediction, the system can detect ransomware in real-time with its online detection process.

Abstract: The present invention relates to a method and an apparatus for synthesizing the voice based on brain waves during imagined speech. The method for synthesizing the voice based on brain waves during imagined speech according to an embodiment of the present invention may include the following steps: a step to obtain the user's brain waves during imagined speech; a step to convert the above-mentioned brain waves of imagined speech into embedding vectors; a step to generate the mel-spectrograms based on the above-mentioned embedding vectors; a step to generate the voice using the above-mentioned mel-spectrograms; a step to output the above-mentioned voice.

Abstract: A system, computer readable medium, apparatus and/or method for non-invasive, non-surgical, digital biopsy. The system, computer readable medium, apparatus and/or method accurately predicts benign kidney lesions from cancers in a patient. A processor may receive patient clinical factors, texture analysis of computer-tomographic imaging, and an artificial intelligence learning model. By implementing artificial intelligence, the processor may then predict or determine a probability of kidney cancer in the patient using the patient clinical factors, the texture analysis of computer-tomographic imaging, and the artificial intelligence learning model. Notably, the prediction is performed without needing invasive biopsy surgery and subsequent pathology analysis to arrive at a diagnosis but relies on radiomics metrics.